NCT05700903 2026-03-02
ARCH
University of Colorado, Denver
Phase 4 Completed
Clinical Trials
63 trialsNCT02651948 2025-12-19
Transperineal, MRI-guided, Prostate Biopsy
University Hospital, Strasbourg, France
Phase 4 Completed
NCT06604442 2025-09-11
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
Blue Earth Diagnostics
Phase 4 Completed
NCT02918968 2024-12-09
Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer
Astellas Pharma Inc
Phase 4 Completed
NCT03035032 2024-11-26
A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients
Astellas Pharma Inc
Phase 4 Completed
NCT01794793 2024-10-01
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
RECORDATI GROUP
Phase 4 Completed
NCT00953277 2024-08-12
Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer
Axogen Corporation
Phase 4 Completed
NCT05803096 2024-01-30
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
Beth Israel Deaconess Medical Center
Phase 4 Completed
NCT01995513 2023-09-18
PLATO
Pfizer
Phase 4 Completed
NCT04074460 2022-06-09
VAPOR-C
Peter MacCallum Cancer Centre, Australia
Phase 4 Completed
NCT03228108 2022-05-10
pro-SWAP
Radboud University Medical Center
Phase 4 Completed
NCT05304169 2022-03-31
PRIZE
Zodiac Produtos Farmaceuticos S.A.
Phase 4 Completed
NCT02726009 2021-12-15
A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer
Ferring Pharmaceuticals
Phase 4 Completed
NCT04776889 2021-03-02
The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients
National Cancer Institute, Egypt
Phase 4 Completed
NCT01753297 2020-12-09
PRIORITI
Ipsen
Phase 4 Completed
NCT02721433 2020-12-02
REaCT-BTA
Ottawa Hospital Research Institute
Phase 4 Completed
NCT02812186 2020-04-08
Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery
Stony Brook University
Phase 4 Completed
NCT02475057 2019-06-12
Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists
Rabin Medical Center
Phase 4 Completed
NCT01136226 2018-10-24
Eligard
Chesapeake Urology Research Associates
Phase 4 Completed
NCT02818816 2018-09-27
IOPsTBURG
University Health Network, Toronto
Phase 4 Completed
NCT00859027 2018-05-01
Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer
UConn Health
Phase 4 Completed
NCT02909049 2018-01-26
Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy
Complexo Hospitalario Universitario de A Coruña
Phase 4 Completed
NCT00245518 2017-10-13
Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy
Johns Hopkins University
Phase 4 Completed
NCT01296672 2017-10-06
3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer
The University of Texas Health Science Center at San Antonio
Phase 4 Completed
NCT00063609 2017-09-13
The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Novartis
Phase 4 Completed
NCT00219271 2017-05-31
Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer
Novartis
Phase 4 Completed
NCT01230905 2017-04-24
AST
Ottawa Heart Institute Research Corporation
Phase 4 Completed
NCT00434447 2017-02-27
Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases
Novartis
Phase 4 Completed
NCT00470834 2017-02-27
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
GlaxoSmithKline
Phase 4 Completed
NCT00237146 2017-02-23
Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy
Novartis
Phase 4 Completed
NCT00242554 2017-02-23
Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases
Novartis
Phase 4 Completed
NCT00434317 2017-02-23
Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases
Novartis
Phase 4 Completed
NCT00334139 2017-02-07
Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer
Novartis
Phase 4 Completed
NCT02441894 2017-01-24
PEGAZUS
Sanofi
Phase 4 Completed
NCT00375765 2017-01-19
Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer
GlaxoSmithKline
Phase 4 Completed
NCT00363311 2017-01-18
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
GlaxoSmithKline
Phase 4 Completed
NCT01571544 2017-01-04
The Use of Thermal Suits as Preventing Hypothermia During Surgery
Tampere University Hospital
Phase 4 Completed
NCT00391690 2016-11-18
Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer
Novartis
Phase 4 Completed
NCT00220194 2016-10-14
A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer
San Bernardino Urological Associates Medical Group Inc
Phase 4 Completed
NCT01649635 2016-07-06
PROSPECTA
Sanofi
Phase 4 Completed
NCT02773251 2016-05-17
The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity Surgery
Bucheon St. Mary's Hospital
Phase 4 Completed
NCT01083199 2016-04-12
Global Performance Evaluation of the AMS CONTINUUM™ Device
American Medical Systems
Phase 4 Completed
NCT02102646 2015-10-28
MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism
Herlev Hospital
Phase 4 Completed
NCT01511874 2015-09-23
Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer
HanAll BioPharma Co., Ltd.
Phase 4 Completed
NCT02149628 2015-07-29
The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide
Yonsei University
Phase 4 Completed
NCT00219219 2015-04-14
Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases
Novartis
Phase 4 Completed
NCT00805701 2014-05-14
Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation
Bay State Clinical Trials, Inc.
Phase 4 Completed
NCT01486563 2013-09-17
VORA
Regional Hospital Holstebro
Phase 4 Completed
NCT01161563 2013-09-06
Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration
Watson Pharmaceuticals
Phase 4 Completed
NCT01547416 2013-07-11
The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function
Yonsei University
Phase 4 Completed